Equities

Tactile Systems Technology Inc

Tactile Systems Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)12.73
  • Today's Change-0.19 / -1.47%
  • Shares traded286.69k
  • 1 Year change-39.44%
  • Beta1.2386
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

  • Revenue in USD (TTM)276.67m
  • Net income in USD28.19m
  • Incorporated2006
  • Employees992.00
  • Location
    Tactile Systems Technology Inc1331 Tyler St NE Ste 200MINNEAPOLIS 55413-1638United StatesUSA
  • Phone+1 (612) 355-5100
  • Fax+1 (612) 355-5101
  • Websitehttps://www.tactilemedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Delcath Systems Inc4.61m-49.79m195.89m76.00--12.27--42.52-2.65-2.650.23570.57470.13820.45454.5660,618.42-149.30-116.57-249.28-243.2170.5471.02-1,080.73-1,235.372.25-42.250.3348---24.05-9.53-30.60---5.26--
Neuropace Inc69.07m-31.51m198.79m171.00--13.84--2.88-1.18-1.182.590.49940.67351.626.63403,935.70-30.72---34.60--73.97---45.61--5.56-4.670.8019--43.72--30.00------
Semler Scientific Inc65.88m21.69m207.24m92.0010.562.619.283.152.782.788.4511.260.85515.138.51716,097.8028.1438.8331.1444.4189.4390.2232.9232.5812.11--0.00--20.2825.9843.6932.64-0.3821--
Butterfly Network Inc68.08m-121.92m209.63m225.00--1.03--3.08-0.5893-0.58930.3290.96850.20450.69544.97302,577.80-36.61---42.07--26.50---179.08--3.34--0.00---10.21--20.76------
Edap Tms SA (ADR)65.63m-19.77m220.95m307.00--3.85--3.37-0.534-0.5341.771.550.63772.393.53213,769.90-19.21-6.62-26.95-9.2240.9143.23-30.12-9.592.00--0.0757--9.649.05-622.06--32.75--
Senseonics Holdings Inc23.30m-80.59m228.28m132.00--12.04--9.80-0.1354-0.13540.0390.10670.16352.516.51176,515.20-56.55-73.65-66.90-106.9712.93-40.41-345.89-649.863.70-11.130.4783--36.623.43-142.49---18.76--
Utah Medical Products, Inc.49.04m16.38m240.96m169.0015.151.9211.154.914.514.5113.5035.600.37272.0913.24290,201.2012.4412.6913.0213.1959.0561.5733.3930.5117.89--0.0037.05-3.933.640.98341.659.711.86
Orchestra Biomed Holdings Inc2.22m-51.64m248.01m56.00--4.34--111.92-1.47-1.470.0631.600.02031.0130.9939,571.43-47.18---52.58--92.06---2,330.46--7.33--0.00---21.88---37.91------
AngioDynamics, Inc.324.01m-192.37m252.74m815.00--1.17--0.7801-4.78-4.788.105.410.74682.666.46397,555.80-44.34-9.12-54.02-10.1750.1754.23-59.37-19.481.62--0.00--7.135.30-97.54--3.55--
Pulmonx Corp72.99m-58.73m281.41m279.00--2.55--3.86-1.54-1.541.912.850.3991.147.81261,627.20-32.11-26.27-35.87-28.9774.3171.95-80.46-93.766.14--0.252--27.9827.98-3.26--20.62--
AxoGen Inc163.73m-21.28m298.50m426.00--3.20--1.82-0.4943-0.49433.802.130.87091.497.04384,333.30-11.32-13.92-12.82-15.8478.3479.74-13.00-20.282.23-8.760.3346--14.7413.6324.98--17.70--
Tactile Systems Technology Inc276.67m28.19m302.49m992.0010.761.568.711.091.181.1811.708.141.016.776.05278,896.2010.300.901512.181.0949.9849.1010.190.83093.63--0.1280.0011.2013.81259.6033.91-23.62--
Zynex Inc188.68m8.17m322.52m1.10k44.899.9325.501.710.22610.22615.391.021.592.526.56171,530.006.8914.588.4117.5280.2279.624.3310.442.877.240.6381--16.5442.01-42.910.37412.19--
Sight Sciences Inc81.50m-54.75m326.40m214.00--2.98--4.01-1.12-1.121.672.200.46281.665.09380,822.40-31.09-38.78-33.65-42.2085.7380.74-67.18-105.1412.42-14.760.2358--13.6360.8435.59--6.77--
Nevro Corp430.75m-82.59m343.41m1.22k--1.23--0.7973-2.28-2.2811.907.590.7361.146.04354,523.50-14.11-13.64-16.06-16.6868.9468.54-19.17-20.675.57--0.4354--4.631.88-3,172.74--0.9012--
Treace Medical Concepts Inc196.03m-54.75m364.61m516.00--2.88--1.86-0.8885-0.88853.182.040.7971.287.07379,905.00-22.26---25.98--80.99---27.93--3.22--0.2958--31.92---15.68------
Data as of May 31 2024. Currency figures normalised to Tactile Systems Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

51.82%Per cent of shares held by top holders
HolderShares% Held
First Light Asset Management LLCas of 31 Mar 20242.64m11.12%
Cadian Capital Management LPas of 31 Mar 20241.93m8.12%
BlackRock Fund Advisorsas of 31 Mar 20241.86m7.84%
The Vanguard Group, Inc.as of 31 Mar 20241.34m5.63%
Perceptive Advisors LLCas of 31 Mar 2024903.09k3.80%
Morgan Stanley & Co. LLCas of 31 Mar 2024853.94k3.59%
Dimensional Fund Advisors LPas of 31 Mar 2024829.20k3.49%
Next Century Growth Investors LLCas of 31 Mar 2024718.97k3.03%
Paradigm Capital Management, Inc.as of 31 Mar 2024622.73k2.62%
SSgA Funds Management, Inc.as of 31 Mar 2024613.68k2.58%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.